Literature DB >> 11049016

An approach for the estimation of drug prescribing using the defined daily dose methodology and drug dispensation data. Theoretical considerations and practical applications.

M Cosentino1, O Leoni, F Banfi, S Lecchini, G Frigo.   

Abstract

OBJECTIVE: To test the hypothesis that comparison of defined daily dose (DDD) and drug user data may help to estimate drug exposure in a defined population and provide information about drug prescribing patterns. METHODS AND
RESULTS: First, comparison of DDD figures with the number of apparent drug users (ADU, i.e., individuals for whom at least one prescription of the drug had been dispensed during a given time period) is demonstrated to correspond to the product of the prescribed daily dose (PDD) and the proportion of days in which the drug had been taken (days of treatment/days in a time period, D). The resulting equation (DDD/day)/ ADU in a time period = PDD x D is then applied to the analysis of different sets of drug dispensation data. Examples show that this approach may be helpful to monitor drug prescribing patterns over time. Moreover, in definite situations, it may provide reliable estimates of either PDD or D.
CONCLUSIONS: Comparison of DDD and drug user data is suggested to be a cost-effective strategy to monitor drug prescribing patterns from an epidemiological perspective, which may be useful to researchers involved in drug utilisation studies as well as to health authorities for monitoring and regulatory purposes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11049016     DOI: 10.1007/s002280000170

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  4 in total

1.  An evaluation of quinolone prescribing in a group of acute hospitals: development of an objective measure of usage.

Authors:  C Curtis; R Fitzpatrick; J F Marriott
Journal:  Pharm World Sci       Date:  2002-04

2.  An antibiotic stewardship program in a surgical ICU of a resource-limited country: financial impact with improved clinical outcomes.

Authors:  Kashif Hussain; Muhammad Faisal Khan; Gul Ambreen; Syed Shamim Raza; Seema Irfan; Kiren Habib; Hasnain Zafar
Journal:  J Pharm Policy Pract       Date:  2020-10-06

3.  Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes?

Authors:  Thomas Grimmsmann; Wolfgang Himmel
Journal:  Eur J Clin Pharmacol       Date:  2011-03-10       Impact factor: 2.953

4.  Defining localities of inadequate treatment for childhood asthma: a GIS approach.

Authors:  Ronit Peled; Haim Reuveni; Joseph S Pliskin; Itzhak Benenson; Erez Hatna; Asher Tal
Journal:  Int J Health Geogr       Date:  2006-01-17       Impact factor: 3.918

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.